ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Taipei City, TWN:

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT/ rilparencel)
Procedure: Sham Comparator

Phase 3

Prokidney

Taipei, Taiwan and 96 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

Taipei City, Taiwan and 89 other locations

with vehicle control in subjects with Wagner Grade 1 to Grade 2 diabetic foot ulcers. Baseline target ulcer size (\<16 cm2 vs ≥16 cm2 ) will...

Enrolling
Diabetes Mellitus
Diabetic Foot Ulcer
Drug: ENERGI-F703 GEL
Drug: ENERGI-F703 matched vehicle

Phase 3

Energenesis Biomedical

Taipei, Taiwan and 23 other locations

New

in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how...

Begins enrollment in 2 months
Diabetes Mellitus, Type 2
Drug: Orforglipron
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Taoyuan, Taiwan and 70 other locations

the efficacy and safety of eloralintide compared with placebo for body weight reduction in participants with overweight or obesity and type 2 diabetes...

Enrolling
Overweight
Obesity
Drug: Eloralintide
Drug: Placebo

Phase 3

Lilly
Lilly

Taipei, Taiwan and 158 other locations

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM an...

Begins enrollment this month
Type 2 Diabetes Mellitus
Drug: Elecoglipron
Drug: Semaglutide

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 157 other locations

The purpose of this clinical study is to look into how well a study medicine called CagriSema helps children and adolescents living with diabetes...

Begins enrollment in 1 month
Diabetes Mellitus, Type 2
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 3

Novo Nordisk
Novo Nordisk

Taipei, Taiwan and 56 other locations

double-blinded, vehicle-controlled, parallel, phase II study to evaluate the efficacy and safety of topical BB-101 for the treatment of diabetic...

Enrolling
Diabetic Foot Ulcer
Biological: BB-101

Phase 2

Blue Blood Biotech

Taipei, Taiwan and 4 other locations

with dapagliflozin compared with placebo in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management alone...

Begins enrollment this month
Type 2 Diabetes Mellitus
Drug: Dapagliflozin
Drug: Dapagliflozin-matched placebo

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 137 other locations

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron, compared with placebo in adults with type 2 diabetes...

Begins enrollment this month
Type 2 Diabetes With Chronic Kidney Disease
Type 2 Diabetes Mellitus
Drug: Elecoglipron
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 161 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems